查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1782005

ELISA 診斷測試市場（按測試類型、按應用、按最終用戶、按國家和地區）－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

ELISA Diagnostics Tests Market, By Test Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年 ELISA 診斷測試市場規模價值 16.9032 億美元，2025 年至 2032 年的複合年成長率為 5.93%。

ELISA 診斷測試市場-市場動態

日益加重的疾病負擔增加了對早期診斷的需求

全球傳染病和慢性病的增加推動了對早期精準診斷方法的需求。 ELISA 檢測至關重要，因為它們能夠在疾病早期檢測出特定的蛋白質、抗原和抗體。賽默飛世爾科技和 Bio-Rad Laboratories 等公司通常使用 ELISA 試劑盒進行早期 HIV 檢測。這有助於改善患者預後並減少傳播。在新冠疫情期間，雅培公司研發了基於 ELISA 的抗體檢測方法，用於識別既往感染。這不僅支持了公共衛生工作，也促進了疫苗的分發。此外，Bio-Techne 還提供 PSA 和 CA-125 等癌症生物標記的 ELISA 試劑盒。這些試劑盒有助於早期診斷和治療監測。這些案例表明，疾病數量的增加正在推動全球對 ELISA 診斷檢測的需求。醫療保健系統正致力於尋找靈敏、經濟且可靠的早期疾病檢測和管理工具。

例如，

2021年10月，西門子醫療推出了一種基於ELISA的新型檢測方法，旨在早期檢測自體免疫疾病，以應對全球範圍內類風濕性關節炎和狼瘡等疾病日益成長的患病率。該產品的推出有助於臨床醫生更早診斷這些複雜的疾病，從而改善患者管理。

ELISA 診斷測試市場—關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 5.93%

根據測試類型細分，預計夾心 ELISA 將在 2024 年佔據最大市場佔有率

根據應用細分，傳染病是 2024 年的主要應用

按地區分類，北美是 2024 年的主要收入來源

ELISA 診斷測試市場-細分分析：

全球 ELISA 診斷測試市場根據測試類型、應用程式、最終用戶和地區進行細分。

根據檢測類型，市場可分為四類：競爭性 ELISA、間接 ELISA、多重及攜帶式 ELISA 和夾心 ELISA。夾心 ELISA 佔據市場主導地位，這得益於其相比其他 ELISA 模式具有更優異的靈敏度和特異性。此方法將目標抗原捕獲在兩層抗體之間，從而提高了檢測血液或血清等複雜樣本中低濃度生物標記的準確性。由於這些優勢，夾心 ELISA 廣泛應用於臨床診斷，應用範圍廣泛，包括傳染病檢測、癌症生物標記識別和荷爾蒙水平測量。其可靠性和提供定量結果的能力使其成為醫療保健提供者和研究實驗室的首選。

根據最終用戶，市場可分為三類：醫院和診斷中心、製藥和生物技術公司、獸醫院和診斷實驗室。醫院和診斷中心佔據市場主導地位。這種主導地位源自於ELISA檢測在臨床疾病診斷、監測和篩檢的廣泛應用。醫院和診斷中心需要可靠、快速的檢測解決方案來管理傳染病、慢性病和其他健康問題，這使得它們成為ELISA試劑盒及相關產品的最大消費者。他們對精準、高通量診斷工具的持續需求，確保了該細分市場相對於製藥公司和獸醫院診實驗室佔據最大的市場佔有率。

ELISA 診斷測試市場-地理洞察

在 2024 年的預測期內，北美將主導全球 ELISA 診斷測試市場。

北美在 ELISA 診斷檢測市場中佔據最大佔有率。這主要得益於其強大的醫療基礎設施和大量的診斷檢測。該地區受益於政府和私營部門在醫學研究和公共衛生方面的大量投資。賽默飛世爾科技、雅培和伯樂實驗室等主要企業推動持續創新，並促進了高品質 ELISA 試劑盒和儀器的普及。美國和加拿大的醫院和實驗室普遍使用 ELISA 檢測來診斷各種傳染病和慢性病。此外，人們對早期疾病檢測的高度認知和優惠的報銷政策也有助於推廣這些檢測。這些因素共同作用，使北美成為該市場的領先地區。

預計在 2024 年的預測期內，亞太地區 ELISA 診斷測試市場的複合年成長率最高。

亞太地區是ELISA診斷檢測市場成長最快的地區。這一成長源於傳染病和生活方式相關疾病的增加。中國、印度和東南亞等國家正在擴大醫療基礎建設，並增加對診斷技術的投入。醫護人員和民眾對早期診斷重要性的認知日益加深，這推動了對ELISA檢測的需求。政府健康計劃和大型篩檢計畫也正在推廣使用像ELISA這樣可靠的診斷工具。此外，ELISA試劑盒價格低廉，在注重預算的醫療機構中頗受歡迎。這些因素正在推動該地區市場顯著成長。

ELISA 診斷測試市場-競爭格局：

ELISA 診斷檢測市場競爭激烈，全球和本地企業均專注於產品創新、建立合作夥伴關係並擴大業務範圍。賽默飛世爾科技、雅培、Bio-Rad Laboratories、丹納赫集團（貝克曼庫爾特）和羅氏製藥等知名企業處於領先地位。他們擁有豐富的 ELISA 檢測產品組合和強大的全球分銷網路。這些公司在研發方面投入巨資，旨在打造靈敏度更高、自動化程度更高、方便用戶使用的 ELISA 系統，以用於臨床和研究應用。 Bio-Techne、RayBiotech、OriGene Technologies 和 Elabscience 等新興和中型公司也日益受到關注。他們專注於特定疾病領域，並提供客製化檢測開發服務。此外，金斯瑞生物科技和歐陸科技等公司正透過合作和本地製造業務拓展亞太和歐洲市場。

多重 ELISA、攜帶式 ELISA 平台和自動化系統等技術創新進一步塑造了這一競爭格局。隨著疾病盛行率的上升以及早期診斷需求的迫切性，競爭也愈演愈烈。各公司都注重經濟實惠、速度和準確性。

最新動態：

2024年5月，默克集團宣布以約6億美元收購Mirus Bio。此次收購不僅專注於病毒載體生產，也增強了默克的下游分析能力，包括基於ELISA的平台。此次收購支持了默克的策略願景，即增強其生命科學產品組合，並推進基因治療和生物製程診斷領域的解決方案。

2023年4月，賽默飛世爾科技公司推出了新一代ELISA試劑盒平台，旨在為臨床和研究環境提供更高的靈敏度和更快的結果。新試劑盒採用先進的訊號檢測技術，可縮短檢測時間並提高各種生物標記分析的一致性。此次發布彰顯了賽默飛世爾科技持續致力於提高全球實驗室診斷精準度和營運效率的承諾。

2023 年 2 月，Abcam plc 推出一系列基於重組單株抗體的全新 ELISA 試劑盒，擴展了其 ELISA 產品組合。這些試劑盒專為癌症和自體免疫疾病研究而設計，可在實驗中提供更高的特異性和一致性。此次發布彰顯了 Abcam 對可重複性和高品質研究工具的承諾，旨在滿足學術界和生物製藥研究界日益成長的需求。

2023年2月，默克集團旗下生命科學部門MilliporeSigma推出了專為臨床前研究中檢測細胞激素和趨化因子而設計的多重ELISA試劑盒。這些試劑盒能夠同時測量多種分析物，進而提升資料深度和檢測效率。此次推出的試劑盒增強了默克在診斷和生命科學領域的影響力，滿足了生物標記發現和轉化研究中對先進工具日益成長的需求。

目錄

第 1 章：ELISA 診斷測試市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • ELISA 診斷測試市場片段（依測試類型）
    • ELISA 診斷測試市場片段（按應用）
    • ELISA 診斷測試市場片段（按最終用戶）
    • ELISA 診斷測試市場（按國家/地區）
    • ELISA 診斷測試市場（按地區）
  • 競爭洞察

第3章：ELISA 診斷測試主要市場趨勢

  • ELISA 診斷測試市場促進因素
    • 市場促進因素的影響分析
  • ELISA 診斷測試市場限制
    • 市場限制的影響分析
  • ELISA 診斷測試市場機遇
  • ELISA 診斷測試市場未來趨勢

第4章：ELISA 診斷測試產業研究

  • PESTEL分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：ELISA 診斷測試市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：ELISA 診斷測試市場格局

  • 2024 年 ELISA 診斷測試市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：ELISA 診斷測試市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 競爭性 ELISA
    • 間接 ELISA
    • 多重及攜帶式 ELISA
    • 夾心 ELISA

第 8 章：ELISA 診斷測試市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 免疫學
    • 發炎
    • 傳染病
    • 癌症
    • 蛋白質定量
    • 其他應用

第9章：ELISA 診斷測試市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和診斷中心
    • 製藥和生物技術公司
    • 獸醫院和診斷實驗室

第 10 章：ELISA 診斷測試市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美 ELISA 診斷測試主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲ELISA診斷測試主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區 ELISA 診斷測試主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲 ELISA 診斷測試主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • ELISA 診斷測試中東和非洲主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依測試類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：關鍵供應商分析 - ELISA 診斷測試產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Abbott
    • Abcam Limited
    • BD
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • BioVision, Inc.
    • Creative Diagnostics
    • Danaher Corporation
    • Elabscience Biotechnology Inc.
    • Enzo Biochem, Inc.
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd
    • GenScript Biotech Corporation
    • Merck KGaA
    • MyBioSource, Inc.
    • OriGene Technologies, Inc.
    • PerkinElme.
    • RayBiotech, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5445

REPORT HIGHLIGHT

ELISA Diagnostics Tests Market size was valued at US$ 1,690.32 Million in 2024, expanding at a CAGR of 5.93% from 2025 to 2032.

The global Enzyme-Linked Immunosorbent Assay (ELISA) market revolves around a diagnostic test designed to detect and measure antibodies in biological samples. By using this test, one can ascertain whether the sample has antibodies against or linked to a particular antigen associated with an infectious disease. As an immunogenic reaction to dangerous chemicals known as pathogens, proteins called antibodies are created to fight invading diseases. The biological process of ELISA involves the adsorption of an antigen onto a solid surface. An enzyme-linked antibody is permitted to be present with the antigen and is identified by the addition of an enzyme specific substrate. The ELISA test is crucial for diagnosing viral illnesses such syphilis, rotavirus, Zika virus, HIV, and the varicella zoster virus, which causes shingles and chickenpox. It is commonly used as a preliminary screening method before more detailed tests and also has applications in pharmaceutical quality control, including endotoxin detection and protein quantification.

ELISA Diagnostics Tests Market- Market Dynamics

Growing disease burden increases demand for early diagnostics

The rise of infectious and chronic diseases worldwide drives the need for early and accurate diagnostic methods. ELISA tests are vital because they can detect specific proteins, antigens, and antibodies early in the disease process. Companies like Thermo Fisher Scientific and Bio-Rad Laboratories commonly use ELISA kits for early HIV detection. This helps improve patient outcomes and reduce transmission. During the COVID-19 pandemic, Abbott created ELISA-based antibody tests to identify prior infections. This supported public health efforts and helped with vaccine distribution. Additionally, Bio-Techne provides ELISA kits for cancer biomarkers like PSA and CA-125. These kits aid in early diagnosis and treatment monitoring. These examples show how the rising number of diseases is increasing the global demand for ELISA diagnostic tests. Healthcare systems are focusing on sensitive, affordable, and reliable tools for early disease detection and management.

For Instance,

In October 2021, Siemens Healthineers launched a new ELISA-based assay designed for the early detection of autoimmune diseases, responding to the rising global prevalence of conditions like rheumatoid arthritis and lupus. This launch helps clinicians diagnose these complex diseases earlier, improving patient management.

ELISA Diagnostics Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.93% over the forecast period (2025-2032)

Based on test type segmentation, sandwich ELISA was predicted to show maximum market share in the year 2024

Based on application segmentation, infectious diseases was the leading application in 2024

On the basis of region, North America was the leading revenue generator in 2024

ELISA Diagnostics Tests Market- Segmentation Analysis:

The global ELISA diagnostics tests market is segmented on the basis of test type, application, end user, and region.

The market is divided into four categories based on test type: competitive ELISA, indirect ELISA, multiple & portable ELISA, sandwich ELISA. The sandwich ELISA sector dominates the market. This is due to its superior sensitivity and specificity compared to other ELISA formats. This method involves capturing the target antigen between two layers of antibodies, which enhances the accuracy of detecting low concentrations of biomarkers in complex samples such as blood or serum. Because of these advantages, Sandwich ELISA is extensively used in clinical diagnostics for a wide range of applications including infectious disease detection, cancer biomarker identification, and hormone level measurement. Its reliability and ability to provide quantitative results make it the preferred choice among healthcare providers and research laboratories.

The market is divided into three categories based on end user: hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories. Hospitals & diagnostic centers dominates the market. This dominance is driven by the widespread use of ELISA tests in clinical settings for disease diagnosis, monitoring, and screening. Hospitals and diagnostic centers require reliable and rapid testing solutions to manage infectious diseases, chronic conditions, and other health concerns, making them the largest consumers of ELISA kits and related products. Their continuous demand for accurate and high throughput diagnostic tools ensures that this segment holds the largest market share compared to pharmaceutical companies and veterinary diagnostic laboratories.

ELISA Diagnostics Tests Market- Geographical Insights

North America dominates the global ELISA diagnostics tests market during the forecast period in 2024.

North America has the largest share in the ELISA Diagnostic Tests market. This is mainly due to its strong healthcare infrastructure and high volumes of diagnostic testing. The region benefits from significant government and private sector investment in medical research and public health. Major players like Thermo Fisher Scientific, Abbott, and Bio-Rad Laboratories drive ongoing innovation and the availability of quality ELISA kits and instruments. Hospitals and labs throughout the U.S. and Canada commonly use ELISA tests to diagnose a variety of infectious and chronic diseases. Moreover, a high level of awareness about early disease detection and favourable reimbursement policies help support widespread use of these tests. Together, these factors make North America the leading region in this market.

Asia Pacific is estimated to register the highest CAGR in the ELISA diagnostics tests market during the forecast period in 2024.

The Asia-Pacific region is seeing the fastest growth in the ELISA Diagnostic Tests market. This growth is due to an increase in infectious and lifestyle related diseases. Countries such as China, India, and Southeast Asian nations are expanding their healthcare infrastructure and investing more in diagnostic technologies. There is a rising awareness among healthcare professionals and the public about the importance of early diagnosis, which is increasing the demand for ELISA-based tests. Government health initiatives and large screening programs are also promoting the use of reliable diagnostic tools like ELISA. Furthermore, the low cost of ELISA kits makes them a popular option in budget-conscious healthcare settings. These factors are driving significant market growth in the region.

ELISA Diagnostics Tests Market- Competitive Landscape:

The ELISA Diagnostic Tests market is filled with competition, featuring a mix of global and local players focused on product innovation, forming partnerships, and expanding their reach. Major names like Thermo Fisher Scientific, Abbott, Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter), and F. Hoffmann-La Roche Ltd. are at the forefront. They have extensive portfolios of ELISA tests and strong global distribution networks. These companies invest heavily in research and development to create ELISA systems that are more sensitive, automated, and user-friendly for clinical and research applications. Emerging and mid-sized companies like Bio-Techne, RayBiotech, OriGene Technologies, and Elabscience are also gaining traction. They target specific disease areas and offer custom assay development. Additionally, firms like GenScript Biotech and Eurofins Scientific are evolving in the Asia-Pacific and European markets through collaborations and local manufacturing efforts.

Technological innovations, such as multiplex ELISA, portable ELISA platforms, and automation systems, further shape this competitive landscape. As disease prevalence increases and the need for early diagnosis becomes urgent, the competition intensifies. Companies are focusing on affordability, speed, and accuracy.

Recent Developments:

In May 2024, Merck KGaA announced the acquisition of Mirus Bio for approximately USD 600 million. While focused on viral vector manufacturing, the acquisition strengthens Merck's downstream analytics capabilities, including ELISA-based platforms. This deal supports the company's strategic vision to enhance its life sciences portfolio and advance solutions in gene therapy and bioprocessing diagnostics

In April 2023, Thermo Fisher Scientific Inc. introduced a next-generation ELISA kit platform aimed at providing enhanced sensitivity and faster results for both clinical and research settings. The new kits incorporate advanced signal detection technology, which shortens assay times and improves consistency across various biomarker analyses. This launch highlights Thermo Fisher's ongoing commitment to advancing diagnostic precision and operational efficiency in laboratories around the globe

In February 2023, Abcam plc expanded its ELISA product portfolio with the launch of a new range of recombinant monoclonal antibody-based ELISA kits. Designed for cancer and autoimmune disease research, these kits deliver enhanced specificity and consistency across experiments. The launch underscores Abcam's commitment to reproducibility and high-quality research tools, supporting the advancing needs of academic and biopharmaceutical research communities

In February 2023, Merck KGaA through its life science division MilliporeSigma, launched multiplex ELISA kits specifically designed for detecting cytokines and chemokines in preclinical research. These kits enable the simultaneous measurement of multiple analytes, improving both data depth and assay efficiency. This launch enhances Merck's presence in the diagnostic and life sciences space, aligning with the growing demand for advanced tools in biomarker discovery and translational research.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELISA DIAGNOSTICS TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Abcam Limited
  • BD
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioVision, Inc.
  • Creative Diagnostics
  • Danaher Corporation
  • Elabscience Biotechnology Inc.
  • Enzo Biochem, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • Merck KGaA
  • MyBioSource, Inc.
  • OriGene Technologies, Inc.
  • PerkinElme.
  • RayBiotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Competitive ELISA
  • Indirect ELISA
  • Multiple & Portable ELISA
  • Sandwich ELISA

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Other Applications

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Veterinary Hospitals & Diagnostic Laboratories

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. ELISA Diagnostics Tests Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. ELISA Diagnostics Tests Market Snippet by Test Type
    • 2.1.2. ELISA Diagnostics Tests Market Snippet by Application
    • 2.1.3. ELISA Diagnostics Tests Market Snippet by End User
    • 2.1.4. ELISA Diagnostics Tests Market Snippet by Country
    • 2.1.5. ELISA Diagnostics Tests Market Snippet by Region
  • 2.2. Competitive Insights

3. ELISA Diagnostics Tests Key Market Trends

  • 3.1. ELISA Diagnostics Tests Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. ELISA Diagnostics Tests Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. ELISA Diagnostics Tests Market Opportunities
  • 3.4. ELISA Diagnostics Tests Market Future Trends

4. ELISA Diagnostics Tests Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ELISA Diagnostics Tests Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. ELISA Diagnostics Tests Market Landscape

  • 6.1. ELISA Diagnostics Tests Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. ELISA Diagnostics Tests Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Competitive ELISA
    • 7.1.3. Indirect ELISA
    • 7.1.4. Multiple & Portable ELISA
    • 7.1.5. Sandwich ELISA

8. ELISA Diagnostics Tests Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Immunology
    • 8.1.3. Inflammation
    • 8.1.4. Infectious diseases
    • 8.1.5. Cancer
    • 8.1.6. Protein quantification
    • 8.1.7. Other Applications

9. ELISA Diagnostics Tests Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Diagnostic Centers
    • 9.1.3. Pharmaceutical & Biotechnology Companies
    • 9.1.4. Veterinary Hospitals & Diagnostic Laboratories

10. ELISA Diagnostics Tests Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. ELISA Diagnostics Tests Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. ELISA Diagnostics Tests Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. ELISA Diagnostics Tests Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. ELISA Diagnostics Tests Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. ELISA Diagnostics Tests Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- ELISA Diagnostics Tests Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Abcam Limited
    • 11.2.3. BD
    • 11.2.4. Bio-Rad Laboratories, Inc.
    • 11.2.5. Bio-Techne Corporation
    • 11.2.6. BioVision, Inc.
    • 11.2.7. Creative Diagnostics
    • 11.2.8. Danaher Corporation
    • 11.2.9. Elabscience Biotechnology Inc.
    • 11.2.10. Enzo Biochem, Inc.
    • 11.2.11. Eurofins Scientific SE
    • 11.2.12. F. Hoffmann-La Roche Ltd
    • 11.2.13. GenScript Biotech Corporation
    • 11.2.14. Merck KGaA
    • 11.2.15. MyBioSource, Inc.
    • 11.2.16. OriGene Technologies, Inc.
    • 11.2.17. PerkinElme.
    • 11.2.18. RayBiotech, Inc.
    • 11.2.19. Siemens Healthineers AG
    • 11.2.20. Thermo Fisher Scientific Inc.
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us